問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2014-01-01 - 2020-12-31
Condition/Disease
Test Drug
Participate Sites7Sites
Terminated7Sites
2011-03-01 - 2012-06-30
Participate Sites6Sites
Terminated6Sites
2002-04-01 - 2015-03-31
Participate Sites5Sites
Terminated5Sites
2012-01-01 - 2015-12-31
2011-09-01 - 2013-12-31
Participate Sites4Sites
Terminated4Sites
2020-06-01 - 2020-05-31
Participate Sites1Sites
Terminated1Sites
2025-07-01 - 2028-12-31
Recruiting1Sites
2023-12-01 - 2026-04-30
Participate Sites3Sites
Recruiting3Sites
2017-02-28 - 2020-02-11
Participate Sites2Sites
Terminated2Sites
Division of Thoracic Medicine
2018-07-01 - 2020-12-31
Hepatocellular Carcinoma
Adagloxad simolenin (OBI-822)/OBI-821
全部
